Maria Nirvana Formiga, MD, PhD

In >230,000 individuals from the Helix Research Network, Lynch syndrome cancer risk varied substantially by gene @JCOOA_ASCO @kellyschiabor MLH1/MSH2 showed the highest colorectal cancer risk, while PMS2 demonstrated markedly lower penetrance & later onset ascopubs.org/doi/pdf/10.120…

For the 1st time in history, there are more people >65 than <5 globally Cancer care is aging and we’re not ready As @WilliamDale_MD highlighted: geriatric + palliative care must become core, not optional @PallOncCoP @realbowtiedoc @RyanNipp @IshwariaMD @DarcyBurbage @JamesFanWu

Two immersive days in #kidneycancer At @GustaveRoussy with amazing Medical Oncology Team @AlbigesL @SoaresAndrey et al #accamargocancercenter

Todo lo que sabemos hoy sobre el cáncer de mama: diagnóstico, tratamientos y factores de riesgo lasedadesdetusalud.telva.com/todo-lo-que-sa… via @uestudio_es @quironsalud @telva @elmundoes

Just started👉2025 United States #ProstateCancer Consensus Conference (USPCCC) 👉with @AlanBryce9 ‘s introductory remarks. @philkuo @cityofhope debating for PSMA PET for treatment selection. Caveat👉 Medical conditions with false positive PSMA PET lesions 👇@urotoday @PCFnews

@walmarthelp Need a answer for my request. #consumerRights

Terrific work in #metastaticrcc Congrats @mzugman and his big mentor @montypal Dr. Tannir Award @ConquerCancerFd @MDAndersonNews @cityofhope

Brilliant talk about #molecularsubtypes #renalcellcarcinoma by @montypal @ASCO #ASCO25

@crisbergerot @PauloBergerot @ASCO @montypal @sarah_c_hopkins @AmandaBinDC @NarjustFlorezMD Congrats!!!!

It wouldn’t be #ASCO25 without our traditional badge selfie! 🎟️📸 @PauloBergerot Anne & I — ready for another year of science, stories, and shared purpose. Let’s do this! 💪🩺 #OncologyFamily #ASCOtradition @ASCO

Socioeconomic inequities in prostate cancer care: private versus public treatment settings pose a significant impact on overall survival doi.org/10.31744/einst… influence of drug access on #overalsurvival #prostatecancer @lucianaholtz @StenioZequi

Excellent overview 1st line therapy in #renalcellcarconoma . Always brilliant talk by @montypal @AlbigesL At #ESMO2024

#ESMO24 @luciana45069110 @AldoLADETTINO @acccancercenter

Wonderful time with colleges from México and Brazil diving in thee prostate cancer Journey @acccancercenter @StenioZequi José Augusto Rinck @thiagocmourao Daniel Garcia @nirvanaformiga @AldoLADETTINO @luciana45069110 @ederbrazaojr Rafael Zanotti

#prostatecancer @OncologyBio Excelente evento de discussão de câncer de próstata! @SoaresAndrey

#SarcomaAwareness @acccancercenter @_CamposFernando #beatcancer

Huge congrats to #NizarTannirMD @MDAndersonNews who drove forward this impt trial (#PIVOT09) comparing pegylated #IL2/#nivolumab to #TKI; was a privelege to work w him & others (@nirvanaformiga @neerajaiims @Daniel_J_George) on this trial now in @JCO_ASCO. PFS & OS no different; RR a bit lower in experimental arm. We saw @brian_rini & @DrChoueiri present genomic data from #KN426 & #CLEAR at #ASCO24 & prev saw genomic data from #CM214 presented by @motzermd. Wish we had the opportunity to look at that here - given modest activity w #bempeg, could offer insights on which pts could get IO monotx - something we discuss often after #KN427 but do infrequently in practice.

A Phase III Randomized Study (PIVOT-09) | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… Honored to have participated in this #RCC trial @acccancercenter With big #GU oncologists Dr. Tannir @MDAndersonNews @montypal @neerajaiims @Daniel_J_George and others

@neerajaiims @BioMedCentral @theNCI @AdrianaMColetta @NeliMUlrich @OncoAlert @PCF_Science @huntsmancancer @urotoday @montypal @umangtalking @maughanonc @soulehoward1 @DrChoueiri @shilpaonc @VivekSubbiah @AzadOncology @Huntsman_GU @EAntonarakis Excellent study @neerajaiims and all team! Congrats! look it that! @AldoLADETTINO @StenioZequi

Just in @BioMedCentral 👉Full protocol of our recently initiated, @theNCI RO1 funded, randomized trial of creatine supplementation + Resistance training in advanced #ProstateCancer undergoing ADT @AdrianaMColetta @NeliMUlrich @OncoAlert @PCF_Science @huntsmancancer @urotoday

Good to discuss with our GU team @StenioZequi @AldoLADETTINO